170 results on '"Laura Valle"'
Search Results
2. MTHFR C677T and A1298C polymorphism’s effect on risk of colorectal cancer in Lynch syndrome
- Author
-
Mariann Unhjem Wiik, Mia Negline, Vidar Beisvåg, Matthew Clapham, Elizabeth Holliday, Nuria Dueñas, Joan Brunet, Marta Pineda, Nuria Bonifaci, Stefan Aretz, Hannah Klinkhammer, Isabel Spier, Claudia Perne, Andreas Mayr, Laura Valle, Jan Lubinski, Wenche Sjursen, Rodney J. Scott, and Bente A. Talseth-Palmer
- Subjects
Medicine ,Science - Abstract
Abstract Lynch syndrome (LS) is characterised by an increased risk of developing colorectal cancer (CRC) and other extracolonic epithelial cancers. It is caused by pathogenic germline variants in DNA mismatch repair (MMR) genes or the EPCAM gene, leading to a less functional DNA MMR system. Individuals diagnosed with LS (LS individuals) have a 10–80% lifetime risk of developing cancer. However, there is considerable variability in the age of cancer onset, which cannot be attributed to the specific MMR gene or variant alone. It is speculated that multiple genetic and environmental factors contribute to this variability, including two single nucleotide polymorphisms (SNPs) in the methylenetetrahydrofolate reductase (MTHFR) gene: C677T (rs1801133) and A1298C (rs1801131). By decreasing MTHFR activity, these SNPs theoretically reduce the silencing of DNA repair genes and increase the availability of nucleotides for DNA synthesis and repair, thereby protecting against early-onset cancer in LS. We investigated the effect of these SNPs on LS disease expression in 2,723 LS individuals from Australia, Poland, Germany, Norway and Spain. The association between age at cancer onset and SNP genotype (risk of cancer) was estimated using Cox regression adjusted for gender, country and affected MMR gene. For A1298C (rs1801131), both the AC and CC genotypes were significantly associated with a reduced risk of developing CRC compared to the AA genotype, but no association was seen for C677T (rs1801133). However, an aggregated effect of protective alleles was seen when combining the alleles from the two SNPs, especially for LS individuals carrying 1 and 2 alleles. For individuals with germline pathogenic variants in MLH1, the CC genotype of A1298C was estimated to reduce the risk of CRC significantly by 39% (HR = 0.61, 95% CI 0.42, 0.89, p = 0.011), while for individuals with pathogenic germline MSH2 variants, the AC genotype (compared to AA) was estimated to reduce the risk of CRC by 26% (HR = 0.66, 95% CI 0.53, 0.83, p = 0.01). In comparison, no association was observed for C677T (rs1801133). In conclusion, our study suggests that combining the MMR gene information with the MTHFR genotype, including the aggregated effect of protective alleles, could be useful in developing an algorithm that estimates the risk of CRC in LS individuals.
- Published
- 2023
- Full Text
- View/download PDF
3. Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1
- Author
-
Pilar Mur, Julen Viana-Errasti, Sandra García-Mulero, Lorena Magraner-Pardo, Inés G. Muñoz, Tirso Pons, Gabriel Capellá, Marta Pineda, Lidia Feliubadaló, and Laura Valle
- Subjects
Polymerase proofreading-associated polyposis ,PPAP ,Polymerase epsilon ,Polymerase delta ,Proofreading deficiency ,Mutational signatures ,Medicine ,Genetics ,QH426-470 - Abstract
Abstract Background Germline variants affecting the proofreading activity of polymerases epsilon and delta cause a hereditary cancer and adenomatous polyposis syndrome characterized by tumors with a high mutational burden and a specific mutational spectrum. In addition to the implementation of multiple pieces of evidence for the classification of gene variants, POLE and POLD1 variant classification is particularly challenging given that non-disruptive variants affecting the proofreading activity of the corresponding polymerase are the ones associated with cancer. In response to an evident need in the field, we have developed gene-specific variant classification recommendations, based on the ACMG/AMP (American College of Medical Genetics and Genomics/Association for Molecular Pathology) criteria, for the assessment of non-disruptive variants located in the sequence coding for the exonuclease domain of the polymerases. Methods A training set of 23 variants considered pathogenic or benign was used to define the usability and strength of the ACMG/AMP criteria. Population frequencies, computational predictions, co-segregation data, phenotypic and tumor data, and functional results, among other features, were considered. Results Gene-specific variant classification recommendations for non-disruptive variants located in the exonuclease domain of POLE and POLD1 were defined. The resulting recommendations were applied to 128 exonuclease domain variants reported in the literature and/or public databases. A total of 17 variants were classified as pathogenic or likely pathogenic, and 17 as benign or likely benign. Conclusions Our recommendations, with room for improvement in the coming years as more information become available on carrier families, tumor molecular characteristics and functional assays, are intended to serve the clinical and scientific communities and help improve diagnostic performance, avoiding variant misclassifications.
- Published
- 2023
- Full Text
- View/download PDF
4. Efeitos da produtividade e da intensidade do trabalho sobre a subjetividade dos trabalhadores
- Author
-
Laura Valle Gontijo
- Subjects
Intensidade do trabalho ,produtividade do trabalho ,jornada de trabalho ,teoria do valor ,subjetividade do trabalho ,Labor. Work. Working class ,HD4801-8943 ,Social sciences (General) ,H1-99 - Abstract
O artigo discute a diferença entre produtividade e intensidade de trabalho e seus efeitos sobre a subjetividade dos trabalhadores à luz teoria do valor, de Marx. A partir de revisão de literatura, o texto demonstrar que, embora os conceitos de produtividade e de intensidade do trabalho sejam muitas vezes tidos como semelhantes, eles produzem impacto diferente na subjetividade dos trabalhadores. Parte-se da hipótese de que, enquanto a produtividade pode ser vista como positiva pelos trabalhadores, a intensidade produz efeito oposto. Conclui-se que tanto intensidade como produtividade podem ser vistas pelo trabalhador como positivas ou negativas, dependendo da forma salarial.
- Published
- 2023
5. Wnt genes in colonic polyposis predisposition
- Author
-
Isabel Quintana, Mariona Terradas, Pilar Mur, Iris B.A.W. te Paske, Sophia Peters, Isabel Spier, Verena Steinke-Lange, Claudia Maestro, David Torrents, Montserrat Puiggròs, Romina Royo, Raul Tonda, Genís Parra, Davide Piscia, Sergi Beltrán, Matilde Navarro, Virginia Piñol, Joan Brunet, Noemi Gonzalez-Abuin, Gemma Aiza, Anna Sommer, Yasmijn van Herwaarden, Galuh Astuti, Elke Holinski-Feder, Nicoline Hoogerbrugge, Richarda M. de Voer, Stefan Aretz, Gabriel Capellá, and Laura Valle
- Subjects
Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Published
- 2023
- Full Text
- View/download PDF
6. Clinical, genetic, epidemiologic, evolutionary, and functional delineation of TSPEAR-related autosomal recessive ectodermal dysplasia 14
- Author
-
Adam Jackson, Sheng-Jia Lin, Elizabeth A. Jones, Kate E. Chandler, David Orr, Celia Moss, Zahra Haider, Gavin Ryan, Simon Holden, Mike Harrison, Nigel Burrows, Wendy D. Jones, Mary Loveless, Cassidy Petree, Helen Stewart, Karen Low, Deirdre Donnelly, Simon Lovell, Konstantina Drosou, Gaurav K. Varshney, Siddharth Banka, J.C. Ambrose, P. Arumugam, R. Bevers, M. Bleda, F. Boardman-Pretty, C.R. Boustred, H. Brittain, M.A. Brown, M.J. Caulfield, G.C. Chan, A. Giess, J.N. Griffin, A. Hamblin, S. Henderson, T.J.P. Hubbard, R. Jackson, L.J. Jones, D. Kasperaviciute, M. Kayikci, A. Kousathanas, L. Lahnstein, A. Lakey, S.E.A. Leigh, I.U.S. Leong, F.J. Lopez, F. Maleady-Crowe, M. McEntagart, F. Minneci, J. Mitchell, L. Moutsianas, M. Mueller, N. Murugaesu, A.C. Need, P. O‘Donovan, C.A. Odhams, C. Patch, D. Perez-Gil, M.B. Pereira, J. Pullinger, T. Rahim, A. Rendon, T. Rogers, K. Savage, K. Sawant, R.H. Scott, A. Siddiq, A. Sieghart, S.C. Smith, A. Sosinsky, A. Stuckey, M. Tanguy, A.L. Taylor Tavares, E.R.A. Thomas, S.R. Thompson, A. Tucci, M.J. Welland, E. Williams, K. Witkowska, S.M. Wood, M. Zarowiecki, Olaf Riess, Tobias B. Haack, Holm Graessner, Birte Zurek, Kornelia Ellwanger, Stephan Ossowski, German Demidov, Marc Sturm, Julia M. Schulze-Hentrich, Rebecca Schüle, Christoph Kessler, Melanie Wayand, Matthis Synofzik, Carlo Wilke, Andreas Traschütz, Ludger Schöls, Holger Hengel, Peter Heutink, Han Brunner, Hans Scheffer, Nicoline Hoogerbrugge, Alexander Hoischen, Peter A.C. ’t Hoen, Lisenka E.L.M. Vissers, Christian Gilissen, Wouter Steyaert, Karolis Sablauskas, Richarda M. de Voer, Erik-Jan Kamsteeg, Bart van de Warrenburg, Nienke van Os, Iris te Paske, Erik Janssen, Elke de Boer, Marloes Steehouwer, Burcu Yaldiz, Tjitske Kleefstra, Anthony J. Brookes, Colin Veal, Spencer Gibson, Marc Wadsley, Mehdi Mehtarizadeh, Umar Riaz, Greg Warren, Farid Yavari Dizjikan, Thomas Shorter, Ana Töpf, Volker Straub, Chiara Marini Bettolo, Sabine Specht, Jill Clayton-Smith, Elizabeth Alexander, Laurence Faivre, Christel Thauvin, Antonio Vitobello, Anne-Sophie Denommé-Pichon, Yannis Duffourd, Emilie Tisserant, Ange-Line Bruel, Christine Peyron, Aurore Pélissier, Sergi Beltran, Ivo Glynne Gut, Steven Laurie, Davide Piscia, Leslie Matalonga, Anastasios Papakonstantinou, Gemma Bullich, Alberto Corvo, Carles Garcia, Marcos Fernandez-Callejo, Carles Hernández, Daniel Picó, Ida Paramonov, Hanns Lochmüller, Gulcin Gumus, Virginie Bros-Facer, Ana Rath, Marc Hanauer, Annie Olry, David Lagorce, Svitlana Havrylenko, Katia Izem, Fanny Rigour, Giovanni Stevanin, Alexandra Durr, Claire-Sophie Davoine, Léna Guillot-Noel, Anna Heinzmann, Giulia Coarelli, Gisèle Bonne, Teresinha Evangelista, Valérie Allamand, Isabelle Nelson, Rabah Ben Yaou, Corinne Metay, Bruno Eymard, Enzo Cohen, Antonio Atalaia, Tanya Stojkovic, Milan Macek, Jr., Marek Turnovec, Dana Thomasová, Radka Pourová Kremliková, Vera Franková, Markéta Havlovicová, Vlastimil Kremlik, Helen Parkinson, Thomas Keane, Dylan Spalding, Alexander Senf, Peter Robinson, Daniel Danis, Glenn Robert, Alessia Costa, Christine Patch, Mike Hanna, Henry Houlden, Mary Reilly, Jana Vandrovcova, Francesco Muntoni, Irina Zaharieva, Anna Sarkozy, Vincent Timmerman, Jonathan Baets, Liedewei Van de Vondel, Danique Beijer, Peter de Jonghe, Vincenzo Nigro, Sandro Banfi, Annalaura Torella, Francesco Musacchia, Giulio Piluso, Alessandra Ferlini, Rita Selvatici, Rachele Rossi, Marcella Neri, Stefan Aretz, Isabel Spier, Anna Katharina Sommer, Sophia Peters, Carla Oliveira, Jose Garcia Pelaez, Ana Rita Matos, Celina São José, Marta Ferreira, Irene Gullo, Susana Fernandes, Luzia Garrido, Pedro Ferreira, Fátima Carneiro, Morris A. Swertz, Lennart Johansson, Joeri K. van der Velde, Gerben van der Vries, Pieter B. Neerincx, Dieuwke Roelofs-Prins, Sebastian Köhler, Alison Metcalfe, Alain Verloes, Séverine Drunat, Caroline Rooryck, Aurelien Trimouille, Raffaele Castello, Manuela Morleo, Michele Pinelli, Alessandra Varavallo, Manuel Posada De la Paz, Eva Bermejo Sánchez, Estrella López Martín, Beatriz Martínez Delgado, F. Javier Alonso García de la Rosa, Andrea Ciolfi, Bruno Dallapiccola, Simone Pizzi, Francesca Clementina Radio, Marco Tartaglia, Alessandra Renieri, Elisa Benetti, Peter Balicza, Maria Judit Molnar, Ales Maver, Borut Peterlin, Alexander Münchau, Katja Lohmann, Rebecca Herzog, Martje Pauly, Alfons Macaya, Anna Marcé-Grau, Andres Nascimiento Osorio, Daniel Natera de Benito, Rachel Thompson, Kiran Polavarapu, David Beeson, Judith Cossins, Pedro M. Rodriguez Cruz, Peter Hackman, Mridul Johari, Marco Savarese, Bjarne Udd, Rita Horvath, Gabriel Capella, Laura Valle, Elke Holinski-Feder, Andreas Laner, Verena Steinke-Lange, Evelin Schröck, and Andreas Rump
- Subjects
TSPEAR ,Ectodermal dysplasia ,Enamel knot ,WNT10A ,Hypodontia ,Conical teeth ,Genetics ,QH426-470 - Abstract
Summary: TSPEAR variants cause autosomal recessive ectodermal dysplasia (ARED) 14. The function of TSPEAR is unknown. The clinical features, the mutation spectrum, and the underlying mechanisms of ARED14 are poorly understood. Combining data from new and previously published individuals established that ARED14 is primarily characterized by dental anomalies such as conical tooth cusps and hypodontia, like those seen in individuals with WNT10A-related odontoonychodermal dysplasia. AlphaFold-predicted structure-based analysis showed that most of the pathogenic TSPEAR missense variants likely destabilize the β-propeller of the protein. Analysis of 100000 Genomes Project (100KGP) data revealed multiple founder TSPEAR variants across different populations. Mutational and recombination clock analyses demonstrated that non-Finnish European founder variants likely originated around the end of the last ice age, a period of major climatic transition. Analysis of gnomAD data showed that the non-Finnish European population TSPEAR gene-carrier rate is ∼1/140, making it one of the commonest AREDs. Phylogenetic and AlphaFold structural analyses showed that TSPEAR is an ortholog of drosophila Closca, an extracellular matrix-dependent signaling regulator. We, therefore, hypothesized that TSPEAR could have a role in enamel knot, a structure that coordinates patterning of developing tooth cusps. Analysis of mouse single-cell RNA sequencing (scRNA-seq) data revealed highly restricted expression of Tspear in clusters representing enamel knots. A tspeara−/−;tspearb−/− double-knockout zebrafish model recapitulated the clinical features of ARED14 and fin regeneration abnormalities of wnt10a knockout fish, thus suggesting interaction between tspear and wnt10a. In summary, we provide insights into the role of TSPEAR in ectodermal development and the evolutionary history, epidemiology, mechanisms, and consequences of its loss of function variants.
- Published
- 2023
- Full Text
- View/download PDF
7. A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants
- Author
-
Mariann Unhjem Wiik, Tiffany-Jane Evans, Sami Belhadj, Katherine A. Bolton, Dagmara Dymerska, Shantie Jagmohan-Changur, Gabriel Capellá, Grzegorz Kurzawski, Juul T. Wijnen, Laura Valle, Hans F. A. Vasen, Jan Lubinski, Rodney J. Scott, and Bente A. Talseth-Palmer
- Subjects
Medicine ,Science - Abstract
Abstract Individuals with Lynch syndrome (LS), have an increased risk of developing cancer. Common genetic variants of telomerase reverse transcriptase (TERT) have been associated with a wide range of cancers, including colorectal cancer (CRC) in LS. We combined genotype data from 1881 LS patients, carrying pathogenic variants in MLH1, MSH2 or MSH6, for rs2075786 (G>A, intronic variant), 1207 LS patients for rs2736108 (C>T, upstream variant) and 1201 LS patients for rs7705526 (C>A, intronic variant). The risk of cancer was estimated by heterozygous/homozygous odds ratio (OR) with mixed-effects logistic regression to adjust for gene/gender/country of sample origin considering family identity. The AA genotype of SNP rs2075786 is associated with 85% higher odds at developing cancer compared to GG genotype in MSH2 pathogenic variant carriers (p = 0.0160). Kaplan–Meier analysis also shows an association for rs2075786; the AA allele for MSH2 variant carriers confers risk for earlier diagnosis of LS cancer (log-rank p = 0.0011). We report a polymorphism in TERT to be a possible modifier of disease risk in MSH2 pathogenic variant carriers. The rs2075786 SNP in TERT is associated with a differential risk of developing cancer for MSH2 pathogenic variant carriers. Use of this information has the potential to personalise screening protocols for LS patients.
- Published
- 2021
- Full Text
- View/download PDF
8. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are infrequent in familial colorectal cancer and polyposis
- Author
-
Pilar Mur, Richarda M. De Voer, Rubén Olivera-Salguero, Sandra Rodríguez-Perales, Tirso Pons, Fernando Setién, Gemma Aiza, Rafael Valdés-Mas, Angelo Bertini, Marta Pineda, Lilian Vreede, Matilde Navarro, Silvia Iglesias, Sara González, Joan Brunet, Alfonso Valencia, Manel Esteller, Conxi Lázaro, Geert J. P. L. Kops, Miguel Urioste, Xose S. Puente, Gabriel Capellá, and Laura Valle
- Subjects
Colorectal cancer predisposition ,Hereditary colorectal cancer ,High-penetrance genes ,Variegated aneuploidy ,Mechanism ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Germline mutations in BUB1 and BUB3 have been reported to increase the risk of developing colorectal cancer (CRC) at young age, in presence of variegated aneuploidy and reminiscent dysmorphic traits of mosaic variegated aneuploidy syndrome. We performed a mutational analysis of BUB1 and BUB3 in 456 uncharacterized mismatch repair-proficient hereditary non-polyposis CRC families and 88 polyposis cases. Four novel or rare germline variants, one splice-site and three missense, were identified in four families. Neither variegated aneuploidy nor dysmorphic traits were observed in carriers. Evident functional effects in the heterozygous form were observed for c.1965-1G>A, but not for c.2296G>A (p.E766K), in spite of the positive co-segregation in the family. BUB1 c.2473C>T (p.P825S) and BUB3 c.77C>T (p.T26I) remained as variants of uncertain significance. As of today, the rarity of functionally relevant mutations identified in familial and/or early onset series does not support the inclusion of BUB1 and BUB3 testing in routine genetic diagnostics of familial CRC.
- Published
- 2018
- Full Text
- View/download PDF
9. The Inherited and Familial Component of Early-Onset Colorectal Cancer
- Author
-
Maria Daca Alvarez, Isabel Quintana, Mariona Terradas, Pilar Mur, Francesc Balaguer, and Laura Valle
- Subjects
hereditary cancer ,cancer genetics ,colorectal cancer predisposition ,cancer syndrome ,lynch syndrome ,polygenic risk score ,Cytology ,QH573-671 - Abstract
Early-onset colorectal cancer (EOCRC), defined as that diagnosed before the age of 50, accounts for 10–12% of all new colorectal cancer (CRC) diagnoses. Epidemiological data indicate that EOCRC incidence is increasing, despite the observed heterogeneity among countries. Although the cause for such increase remains obscure, ≈13% (range: 9–26%) of EOCRC patients carry pathogenic germline variants in known cancer predisposition genes, including 2.5% of patients with germline pathogenic variants in hereditary cancer genes traditionally not associated with CRC predisposition. Approximately 28% of EOCRC patients have family history of the disease. This article recapitulates current evidence on the inherited syndromes that predispose to EOCRC and its familial component. The evidence gathered support that all patients diagnosed with an EOCRC should be referred to a specialized genetic counseling service and offered somatic and germline pancancer multigene panel testing. The identification of a germline pathogenic variant in a known hereditary cancer gene has relevant implications for the clinical management of the patient and his/her relatives, and it may guide surgical and therapeutic decisions. The relative high prevalence of hereditary cancer syndromes and familial component among EOCRC patients supports further research that helps understand the genetic background, either monogenic or polygenic, behind this increasingly common disease.
- Published
- 2021
- Full Text
- View/download PDF
10. Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.
- Author
-
Nuria Seguí, Elisabet Guinó, Marta Pineda, Matilde Navarro, Fernando Bellido, Conxi Lázaro, Ignacio Blanco, Victor Moreno, Gabriel Capellá, and Laura Valle
- Subjects
Medicine ,Science - Abstract
Aberrant telomere length measured in blood has been associated with increased risk of several cancer types. In the field of hereditary non-polyposis colorectal cancer (CRC), and more particularly in Lynch syndrome, caused by germline mutations in the mismatch repair (MMR) genes, we recently found that cancer-affected MMR gene mutation carriers had shorter telomeres and more pronounced shortening of telomere length with age than controls and unaffected MMR gene mutation carriers. Here we evaluate blood telomere length in MMR-proficient hereditary non-polyposis CRC, i.e. familial CRC type X (fCRC-X). A total of 57 cancer-affected and 57 cancer-free individuals from 34 Amsterdam-positive fCRC-X families were analyzed and compared to the data previously published on 144 cancer-affected and 100 cancer-free MMR gene mutation carriers, and 234 controls. Relative telomere length was measured using a monochrome multiplex quantitative PCR method, following strict measures to avoid sources of bias and adjusting by age. Despite the retrospective nature of our study, the results show that longer telomeres associate with cancer risk in fCRC-X, thus identifying different patterns of telomere length according to the status of the MMR system.
- Published
- 2014
- Full Text
- View/download PDF
11. Telomere length and genetic anticipation in Lynch syndrome.
- Author
-
Nuria Seguí, Marta Pineda, Elisabet Guinó, Ester Borràs, Matilde Navarro, Fernando Bellido, Victor Moreno, Conxi Lázaro, Ignacio Blanco, Gabriel Capellá, and Laura Valle
- Subjects
Medicine ,Science - Abstract
Telomere length variation has been associated with increased risk of several types of tumors, and telomere shortening, with genetic anticipation in a number of genetic diseases including hereditary cancer syndromes. No conclusive studies have been performed for Lynch syndrome, a hereditary colorectal cancer syndrome caused by germline mutations in the DNA mismatch repair genes. Here we evaluate telomere length in Lynch syndrome, both as a cancer risk factor and as a mechanism associated with anticipation in the age of cancer onset observed in successive generations of Lynch syndrome families. Leukocyte telomere length was measured in 244 mismatch repair gene mutation carriers from 96 Lynch syndrome families and in 234 controls using a monochrome multiplex quantitative PCR method. Cancer-affected mutation carriers showed significantly shorter telomeres than cancer-free mutation carriers. In addition, cancer-affected carriers showed the most pronounced shortening of telomere length with age, compared with unaffected carriers. The anticipation in the age of cancer onset observed in successive generations was not associated with telomere shortening, although, interestingly, all mother-son pairs showed telomere shortening. In conclusion, cancer-affected mismatch repair gene mutation carriers have distinct telomere-length pattern and dynamics. However, anticipation in the age of onset is not explained by telomere shortening. Pending further study, our findings suggest that telomere attrition might explain the previously reported dependence of cancer risk on the parent-of-origin of mismatch repair gene mutations.
- Published
- 2013
- Full Text
- View/download PDF
12. Italy
- Author
-
Laura, Valle, primary
- Published
- 2023
- Full Text
- View/download PDF
13. Platform work and Marx's theory of value: a literature review.
- Author
-
Gontijo, Laura Valle and Peleja, João Pedro Inácio
- Abstract
This article aims to investigate the academic production of platform work and its interfaces with Marx's theory of value in the field of Social and Economic Sciences. A systematic review of the international literature produced between 2009 and 2023 was carried on the Scopus database. The question of the creation of value is the most important aspect that has been identified by this research. Most of the authors affirmed that data creates value. We indicated the critics that exist on this topic. For instance, the formal and real subsumption of labor to capital and the importance that money plays in materializing value. Also, piece-rate pay was identified as an important aspect that affects workers' subjectivity to increase the creation of value. In addition, the authors explored the process of concentration and centralization of capital in the platform economy. This literature review concludes that there is still a lack of studies on platform work from a value theory perspective. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Characterization of POLE c.1373A > T p.(Tyr458Phe), causing high cancer risk
- Author
-
Mariève J. Rocque, Vilde Leipart, Ashish Kumar Singh, Pilar Mur, Maren F. Olsen, Lars F. Engebretsen, Edgar Martin-Ramos, Rosa Aligué, Pål Sætrom, Laura Valle, Finn Drabløs, Marit Otterlei, and Wenche Sjursen
- Subjects
Genetics ,General Medicine ,Molecular Biology - Abstract
The cancer syndrome polymerase proofreading-associated polyposis results from germline mutations in the POLE and POLD1 genes. Mutations in the exonuclease domain of these genes are associated with hyper- and ultra-mutated tumors with a predominance of base substitutions resulting from faulty proofreading during DNA replication. When a new variant is identified by gene testing of POLE and POLD1, it is important to verify whether the variant is associated with PPAP or not, to guide genetic counseling of mutation carriers. In 2015, we reported the likely pathogenic (class 4) germline POLE c.1373A > T p.(Tyr458Phe) variant and we have now characterized this variant to verify that it is a class 5 pathogenic variant. For this purpose, we investigated (1) mutator phenotype in tumors from two carriers, (2) mutation frequency in cell-based mutagenesis assays, and (3) structural consequences based on protein modeling. Whole-exome sequencing of two tumors identified an ultra-mutator phenotype with a predominance of base substitutions, the majority of which are C > T. A SupF mutagenesis assay revealed increased mutation frequency in cells overexpressing the variant of interest as well as in isogenic cells encoding the variant. Moreover, exonuclease repair yeast-based assay supported defect in proofreading activity. Lastly, we present a homology model of human POLE to demonstrate structural consequences leading to pathogenic impact of the p.(Tyr458Phe) mutation. The three lines of evidence, taken together with updated co-segregation and previously published data, allow the germline variant POLE c.1373A > T p.(Tyr458Phe) to be reclassified as a class 5 variant. That means the variant is associated with PPAP.
- Published
- 2023
15. O trabalho em plataformas digitais e o salário por peça
- Author
-
Laura Valle Gontijo
- Subjects
General Medicine - Abstract
Este artigo tem como objetivo oferecer contribuições à compreensão do trabalho em plataformas digitais a partir da sua forma de remuneração. O salário por peça é identificado, na teoria do valor de Marx, como uma forma de remuneração que permite o aumento da produtividade e da intensidade do trabalho, assim como o prolongamento da jornada de trabalho, com particular incidência sobre a subjetividade dos trabalhadores. Foi realizada uma revisão bibliográfica da literatura mais recente sobre o trabalho em plataformas digitais e da literatura acerca do conceito de salário por peça, tendo como principal referência o volume I do livro “O Capital”, de Marx. Em seguida, foram construídas categorias a partir das características do salário por peça identificadas na revisão de literatura, que nortearam a elaboração de um questionário. O questionário foi aplicado entre maio e julho de 2021 com 87 entregadores em plataformas digitais, em 19 estados do país. A hipótese que norteou esse estudo é a de que o trabalho em plataformas digitais promove um retorno do salário por peça. Os resultados da aplicação do questionário confirmaram a hipótese e colocaram em destaque a importância que possui a forma de remuneração para compreender a disposição desses trabalhadores em perfazer longas jornadas e suportar péssimas condições de trabalho. Sugere-se a realização de mais estudos para um melhor entendimento da relação entre salário por peça e trabalho em plataformas digitais.
- Published
- 2023
16. Germline mutations inWNK2could be associated with serrated polyposis syndrome
- Author
-
Yasmin Soares de Lima, Coral Arnau-Collell, Jenifer Muñoz, Cristina Herrera-Pariente, Leticia Moreira, Teresa Ocaña, Marcos Díaz-Gay, Sebastià Franch-Expósito, Miriam Cuatrecasas, Sabela Carballal, Anael Lopez-Novo, Lorena Moreno, Guerau Fernàndez, Aranzazu Díaz de Bustamante, Sophia Peters, Anna K Sommer, Isabel Spier, Iris B A W te Paske, Yasmijn J van Herwaarden, Antoni Castells, Luis Bujanda, Gabriel Capellà, Verena Steinke-Lange, Khalid Mahmood, JiHoon Eric Joo, Julie Arnold, Susan Parry, Finlay A Macrae, Ingrid M Winship, Christophe Rosty, Joaquin Cubiella, Daniel Rodríguez-Alcalde, Elke Holinski-Feder, Richarda de Voer, Daniel D Buchanan, Stefan Aretz, Clara Ruiz-Ponte, Laura Valle, Francesc Balaguer, Laia Bonjoch, and Sergi Castellvi-Bel
- Subjects
All institutes and research themes of the Radboud University Medical Center ,Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14] ,Genetics ,Genetics (clinical) - Abstract
BackgroundPatients with serrated polyposis syndrome (SPS) have multiple and/or large serrated colonic polyps and higher risk for colorectal cancer. SPS inherited genetic basis is mostly unknown. We aimed to identify new germline predisposition factors for SPS by functionally evaluating a candidate gene and replicating it in additional SPS cohorts.MethodsAfter a previous whole-exome sequencing in 39 SPS patients from 16 families (discovery cohort), we sequenced specific genes in an independent validation cohort of 211 unrelated SPS cases. Additional external replication was also available in 297 SPS cases. TheWNK2gene was disrupted in HT-29 cells by gene editing, andWNK2variants were transfected using a lentiviral delivery system. Cells were analysed by immunoblots, real-time PCR and functional assays monitoring the mitogen-activated protein kinase (MAPK) pathway, cell cycle progression, survival and adhesion.ResultsWe identified 2 rare germline variants in theWNK2gene in the discovery cohort, 3 additional variants in the validation cohort and 10 other variants in the external cohorts. Variants c.2105C>T (p.Pro702Leu), c.4820C>T (p.Ala1607Val) and c.6157G>A (p.Val2053Ile) were functionally characterised, displaying higher levels of phospho-PAK1/2, phospho-ERK1/2, CCND1, clonogenic capacity and MMP2.ConclusionAfter whole-exome sequencing in SPS cases with familial aggregation and replication of results in additional cohorts, we identified rare germline variants in theWNK2gene. Functional studies suggested germlineWNK2variants affect protein function in the context of the MAPK pathway, a molecular hallmark in this disease.
- Published
- 2022
17. Industry and Inclusion: Highlights from Community Colleges
- Author
-
Michelle Burris, Michelle Burris, Tanu Kumar, Laura Valle-Gutierrez, Emily McGrath, Michelle Burris, Michelle Burris, Tanu Kumar, Laura Valle-Gutierrez, and Emily McGrath
- Abstract
The report provides actionable recommendations for community colleges desiring to provide inclusive programming that supports the recruitment, enrollment and credentialing of historically marginalized students in the Advanced Manufacturing sector. It also provides recommendations for policymakers to focus investments and strategies in support of this work.
- Published
- 2023
18. Lynch Syndrome: A Single Hereditary Cancer Syndrome or Multiple Syndromes Defined by Different Mismatch Repair Genes?
- Author
-
Laura Valle
- Subjects
Hepatology ,Gastroenterology - Published
- 2023
19. Lack of evidence for germline WWP1 pathogenic variants in gastrointestinal polyposis and other phenotypes suggestive of PTEN-hamartoma-tumor syndrome
- Author
-
Noemi Gonzalez-Abuin, Tirso Pons, Teresa Fuster, Isabel Quintana, Mariona Terradas, Gemma Aiza, Joan Brunet, Gabriel Capellá, Heather Hampel, and Laura Valle
- Subjects
Cell Biology ,Molecular Biology ,Biochemistry ,Genetics (clinical) - Published
- 2023
20. Supplementary Table 2 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
List of primers used in Sanger sequencing and SNPs utilized to genotype the 84 normal adjacent and tumor samples.
- Published
- 2023
21. Supplementary Table 6 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
List of recurrent mutated genes ranked by MutSig tool.
- Published
- 2023
22. supplementary material legends from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
supplementary material legends (tables and figures)
- Published
- 2023
23. Supplementary Table 1 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
Baseline characteristics of CRC patients (discovery dataset, Sanger validation dataset and TCGA datasets).
- Published
- 2023
24. Supplementary Figures from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
Supplementary Figures (1 to 15)
- Published
- 2023
25. Supplementary Table 5 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
Mutations validated in Biomark platform (Fluidigm) and by Sanger Sequencing.
- Published
- 2023
26. Supplementary Table 3 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
List of all SNVs found
- Published
- 2023
27. Supplementary Table 4 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
List of recurrent mutations
- Published
- 2023
28. Supplementary Table 7 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
List of statistically significant functions in which mutated genes are implicated.
- Published
- 2023
29. Supplementary Table 8 from Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer
- Author
-
Victor Moreno, Laura Valle, Ramón Salazar, Antonio Soriano, Francisco D. Morón-Duran, David Cordero, Adria Closa, Xavier Sanjuan, Marta Gut, Francesc Castro-Giner, Sergi Beltrán, Elisabet Guinó, Susanna Aussó, M. Henar Alonso, Fernando Bellido, Kira Lázaro, Laia Paré-Brunet, Adriana Lopez-Doriga, and Rebeca Sanz-Pamplona
- Abstract
Mutations found in AMER1 gene across different datasets
- Published
- 2023
30. Supplementary Figure 1 from Tgfbr1 Haploinsufficiency Is a Potent Modifier of Colorectal Cancer Development
- Author
-
Boris Pasche, Albert de la Chapelle, Antonio Di Cristofano, Laura Valle, Chiang-Ching Huang, Guang-Yu Yang, Jie Liao, Michael Pennison, Diana S. Rosman, Maureen Sadim, Yanfei Xu, Sharbani Phukan, and Qinghua Zeng
- Abstract
Supplementary Figure 1 from Tgfbr1 Haploinsufficiency Is a Potent Modifier of Colorectal Cancer Development
- Published
- 2023
31. O trabalho em plataformas digitais e o salário por peça
- Author
-
Gontijo, Laura Valle, primary
- Published
- 2023
- Full Text
- View/download PDF
32. Co-occurring mutations in the POLE exonuclease and non-exonuclease domains define a unique subset of highly mutagenic tumors
- Author
-
Shreya M. Shah, Elena V. Demidova, Salena Ringenbach, Bulat Faezov, Mark Andrake, Pilar Mur, Julen Viana-Errasti, Joanne Xiu, Jeffrey Swensen, Laura Valle, Roland L. Dunbrack, Michael J. Hall, and Sanjeevani Arora
- Abstract
SomaticPOLEmutations in the exonuclease domain (ExoD) are prevalent in colorectal cancer (CRC), endometrial cancer (EC), and others and typically lead to dramatically increased tumor mutation burden (TMB). To understand whether non-ExoD mutations also play a role in mutagenesis, we assessed TMB in 447/14541POLE-mutated CRCs, ECs, and ovarian cancers (OC) based on classification TMB-High (TMB-H) or TMB-Low (TMB-L). TMB-H tumors were segregated as ‘POLEExoD driver’, ‘POLEExoD driver plusPOLEVariant’, and ‘POLEVariant TMB-H’. Intriguingly, TMB was highest in tumors bearing ‘POLEExoD driver plusPOLEVariant’ (pPOLEvariants categorize a unique subset ofPOLE-driven tumors defined by ultra-high TMB, which has implications for abundance of tumor neoantigens, therapeutic response, and patient outcomes.SignificanceSomaticPOLEExoD driver mutations cause proofreading deficiency that induces high tumor mutation burden (TMB). This study defines a novel modifier role for non-ExoD mutations inPOLEExoD-driven tumors, associated with ultra-high TMB. These data may inform acquisition of tumor neoantigens, tumor classification, therapeutic response, and patient outcomes.
- Published
- 2022
33. Solving the enigma of POLD1 p.V295M as a potential cause of increased cancer risk
- Author
-
Rebeca Sanz-Pamplona, Conxi Lázaro, Tirso Pons, Sandra García-Mulero, Laura Valle, Jesús del Valle, Elsa Ezquerro, Lorena Magraner-Pardo, Pilar Mur, Gabriel Capellá, Victor Moreno, and Anna Díez-Villanueva
- Subjects
Adenoma ,Genetics ,Exonuclease ,POLD1 ,biology ,Cancer ,DNA Polymerase II ,Brief Communication ,medicine.disease ,Germline ,Frameshift mutation ,biology.protein ,medicine ,Humans ,Missense mutation ,Proofreading ,Colorectal Neoplasms ,Poly-ADP-Ribose Binding Proteins ,Germ-Line Mutation ,Genetics (clinical) ,Polymerase ,DNA Polymerase III - Abstract
Germline variants that affect the proofreading activity of polymerases epsilon (POLE) and delta (POLD1) predispose to colorectal adenomas and carcinomas, among other cancers. All cancer-associated pathogenic variants reported to date consist of non-disruptive genetic changes affecting the sequence that codifies the exonuclease domain (ED). Generally, disruptive (frameshift, stop-gain) POLE and POLD1 variants and missense variants outside the ED do not predispose to cancer. However, this statement may not be true for some, very specific variants that would indirectly affect the proofreading activity of the corresponding polymerase. We evaluated, by using multiple approaches, the possibility that POLD1 c.883G>A; p.(Val295Met), -a variant located 9 amino acids upstream the ED and present in ~0.25% of hereditary cancer patients-, affects POLD1 proofreading activity. Our findings show cumulative evidence that support no alteration of the proofreading activity and lack of association with cancer. The variant is classified as likely benign according to the ACMG/AMP guidelines.
- Published
- 2021
34. Extended family with an inherited pathogenic variant in polymerase delta provides strong evidence for recessive effect of proofreading deficiency in human cells
- Author
-
Maria A. Andrianova, Vladimir B. Seplyarskiy, Mariona Terradas, Ana Beatriz Sánchez-Heras, Pilar Mur, José Luis Soto, Gemma Aiza, Fyodor A. Kondrashov, Alexey S. Kondrashov, Georgii A. Bazykin, and Laura Valle
- Abstract
Mutational processes in germline and in somatic cells are vastly different, and it remains unclear how the same genetic background affects somatic and transmissible mutations. Here, we estimate the impact of an inherited pathogenic variant in the exonuclease domain of polymerase delta (Polδ) on somatic and germline mutational processes and cancer development. In germline cells and in non-cancer somatic cells, thePOLD1L474P variant increases the mutation burden only slightly, contributing ∼11.8% and ∼14.7% of mutations respectively, although it strongly distorts the mutational spectra. By contrast, tumors developed by carriers of inherited pathogenic variants inPOLD1harbor a DNA rearrangement that results in a homozygous state of the pathogenic variant, leading to an extremely high mutation rate. Thus, mutations in both alleles ofPOLD1gene are required for strong increase in mutation rate suggesting recessiveness of Poldδ proofreading. These results show a similar role of Polδ in germline and somatic replication, and, together with previous findings, illustrate the important differences between Polδ and Polε in the disruption of their replication fidelity.
- Published
- 2022
35. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype
- Author
-
Rossella Tricarico, Jozef Madzo, Gabrielle Scher, Maya Cohen, Jaroslav Jelinek, Shinji Maegawa, Rajeswari Nagarathinam, Carly Scher, Wen-Chi Chang, Emmanuelle Nicolas, Michael Slifker, Yan Zhou, Karthik Devarajan, Kathy Q. Cai, Tim Kwok, Pamela Nakajima, Jinfei Xu, Pietro Mancuso, Valentina Doneddu, Luigi Bagella, Riley Williams, Siddharth Balachandran, Nicholas Maskalenko, Kerry Campbell, Xueying Ma, Israel Cañadas, Julen Viana-Errasti, Victor Moreno, Laura Valle, Sergei Grivennikov, Iuliia Peshkova, Natalia Kurilenko, Aleksandra Mazitova, Ekaterina Koltsova, Hayan Lee, Martin Walsh, Reuben Duttweiler, Johnathan R. Whetstine, Timothy J. Yen, Jean-Pierre Issa, and Alfonso Bellacosa
- Subjects
Hepatology ,Gastroenterology - Published
- 2023
36. Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) onAPCI1307K and cancer risk
- Author
-
Laura Valle, Lior H Katz, Andrew Latchford, Pilar Mur, Victor Moreno, Ian M Frayling, Brandie Heald, and Gabriel Capellá
- Subjects
Genetics ,Genetics (clinical) - Abstract
While constitutional pathogenic variants in theAPCgene cause familial adenomatous polyposis,APCc.3920T>A; p.Ile1307Lys (I1307K) has been associated with a moderate increased risk of colorectal cancer (CRC), particularly in individuals of Ashkenazi Jewish descent. However, published data include relatively small sample sizes, generating inconclusive results regarding cancer risk, particularly in non-Ashkenazi populations. This has led to different country/continental-specific guidelines regarding genetic testing, clinical management and surveillance recommendations for I1307K. A multidisciplinary international expert group endorsed by the International Society for Gastrointestinal Hereditary Tumours (InSiGHT), has generated a position statement on theAPCI1307K allele and its association with cancer predisposition. Based on a systematic review and meta-analysis of the evidence published, the aim of this document is to summarise the prevalence of theAPCI1307K allele and analysed the evidence of the associated cancer risk in different populations. Here we provide recommendations on the laboratory classification of the variant, define the role of predictive testing for I1307K, suggest recommendations for cancer screening in I1307K heterozygous and homozygous individuals and identify knowledge gaps to be addressed in future research studies. Briefly, I1307K, classified as pathogenic, low penetrance, is a risk factor for CRC in individuals of Ashkenazi Jewish origin and should be tested in this population, offering carriers specific clinical surveillance. There is not enough evidence to support an increased risk of cancer in other populations/subpopulations. Therefore, until/unless future evidence indicates otherwise, individuals of non-Ashkenazi Jewish descent harbouring I1307K should be enrolled in national CRC screening programmes for average-risk individuals.
- Published
- 2023
37. Tracheostomy in patients with high suspicion or diagnosis of COVID-19: case series from two hospitals in Northwestern Mexico
- Author
-
Edwin Canche Martin, Eduardo González Quintana, Fernanda Verana Barragán Márquez, Nohemí Sainz Fuentes, Juan Antonio Lugo-Machado, Alfonso Antonio Rubio Espinoza, José Roberto Reina Loaiza, Laura Valle Soto, and Oscar Said Rodríguez Quintana
- Subjects
medicine.medical_specialty ,Series (stratigraphy) ,Coronavirus disease 2019 (COVID-19) ,business.industry ,General surgery ,General Medicine ,03 medical and health sciences ,0302 clinical medicine ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Medicine ,In patient ,030223 otorhinolaryngology ,business - Abstract
OBJECTIVE. To describe the results of tracheostomy in a series of cases in patients with COVID-19 admitted to the intensive care unit in two hospitals in the Northwest Mexico. MATERIAL AND METHODS. A prospective, descriptive, longitudinal study was carried out on a series of cases from April 2020 to August 2020. Data such as age, sex, hospital of origin, risk factors for the development of severe COVID-19, ventilatory and gasometric parameters before and 72 hours after, the days of oro-tracheal intubation were taken into account. Descriptive statistics with frequencies and percentages were used for the qualitative variables, for the numerical measures of central tendency as the mean and the median, the distribution of the results. RESULTS. From April to August 2020, in the two Intensive Care Units (ICUs) of these hospitals, 134 COVID-19 cases were admitted. In 14 patients (10.4%) tracheotomies were performed, 13 (92.8%) were male, mean age 49.21 years, 85% tested positive. The mean duration of oro-tracheal intubation was 22.7. Obesity combined with diabetes and arterial hypertension represented a risk factor in 57.1% of the cases. In 10 patients, the procedure was performed in the ICU bed. There were changes in some ventilatory parameters before and 72 hours after the procedure. The average number of days after weaning from the ventilator was 5.5 days. There were 3 deaths in our series. CONCLUSION. The adequate and prudent selection of COVID-19 patients for tracheostomy makes it easier to choose with greater justification the patients with the best prognosis, avoiding unnecessary procedures in a patient and a greater risk of contagion in the personnel.
- Published
- 2021
38. Role of POLE and POLD1 in familial cancer
- Author
-
Pau M. Munoz-Torres, Joan Brunet, Rebeca Sanz-Pamplona, August Vidal, Gemma Llort, Esther Darder, Victor Moreno, Teresa Ramón y Cajal, Laura Valle, Judith Balmaña, Marta Pineda, Tirso Pons, Xavier Matias-Guiu, Jesús del Valle, Lorena Magraner-Pardo, Rosa Aligué, Pilar Mur, Giacomo Cinnirella, Josep M. Piulats, Elia Grau, Lídia Feliubadaló, Sami Belhadj, Adriana Lopez-Doriga, Matilde Navarro, Conxi Lázaro, Sandra García-Mulero, Judit Sanz, Gabriel Capellá, Edgar Martin-Ramos, [Mur P, Del Valle J, Pineda M] Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. [García-Mulero S] Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. [Magraner-Pardo L] Prostate Cancer Clinical Research Unit. Spanish National Cancer Research Center (CNIO), Madrid, Spain. [Vidal A] Department of Pathology, Bellvitge University Hospital, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. [Balmana J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Ministerio de Economía y Competitividad (España), Instituto de Salud Carlos III, Generalitat de Catalunya, Fundación Olga Torres, and European Cooperation in Science and Technology
- Subjects
fenómenos genéticos::variación genética::mutación::mutación de la línea germinal [FENÓMENOS Y PROCESOS] ,Proband ,Polymerase proofreading–associated polyposis ,Recte - Càncer - Aspectes genètics ,Colorectal cancer ,Genetic counseling ,Population ,Còlon - Càncer - Aspectes genètics ,Biology ,Article ,Genetic Phenomena::Genetic Variation::Mutation::Germ-Line Mutation [PHENOMENA AND PROCESSES] ,Germline ,PPAP ,Endometrial cancer ,Càncer colorectal ,Malalties hereditàries ,Ultramutated phenotype ,medicine ,Humans ,Missense mutation ,Poly-ADP-Ribose Binding Proteins ,education ,Allele frequency ,Germ-Line Mutation ,Genetics (clinical) ,Exonuclease domain ,DNA Polymerase III ,Genetics ,education.field_of_study ,Malalties transmissibles - Teoria germinal ,POLD1 ,ultramutated phenotype ,DNA Polymerase II ,medicine.disease ,polymerase proofreading–associated polyposis ,Càncer d'endometri ,Neoplasms::Neoplasms::Neoplastic Syndromes, Hereditary::Colorectal Neoplasms, Hereditary Nonpolyposis [DISEASES] ,Hereditary colorectal cancer ,Mutation ,hereditary colorectal cancer ,neoplasias::neoplasias::síndromes neoplásicos hereditarios::neoplasias colorrectales hereditarias sin poliposis [ENFERMEDADES] ,exonuclease domain ,Colorectal Neoplasms ,Genetic diseases - Abstract
[Purpose]: Germline pathogenic variants in the exonuclease domain (ED) of polymerases POLE and POLD1 predispose to adenomatous polyps, colorectal cancer (CRC), endometrial tumors, and other malignancies, and exhibit increased mutation rate and highly specific associated mutational signatures. The tumor spectrum and prevalence of POLE and POLD1 variants in hereditary cancer are evaluated in this study. [Methods]: POLE and POLD1 were sequenced in 2813 unrelated probands referred for genetic counseling (2309 hereditary cancer patients subjected to a multigene panel, and 504 patients selected based on phenotypic characteristics). Cosegregation and case–control studies, yeast-based functional assays, and tumor mutational analyses were performed for variant interpretation. [Results]: Twelve ED missense variants, 6 loss-of-function, and 23 outside-ED predicted-deleterious missense variants, all with population allele frequencies, This work was funded by the Spanish Ministry of Science and Innovation, cofunded by FEDER funds (SAF2016-80888-R, SAF2015-68016-R, Severo Ochoa SVP-2014-068895 contract [L.M.-P.]); Instituto de Salud Carlos III (PI16/00563, PI16/00588, PI14/00613, PI19/00553, CIBERONC CB16/12/00234, CIBERESP, Sara Borrell contract [P.M.]); Government of Catalonia [AGAUR 2017SGR1282, CERCA Program]; and Fundación Olga Torres. This study was facilitated by COST Action CA17118, supported by COST (European Cooperation in Science and Technology).
- Published
- 2020
39. Germline mutations in
- Author
-
Yasmin, Soares de Lima, Coral, Arnau-Collell, Jenifer, Muñoz, Cristina, Herrera-Pariente, Leticia, Moreira, Teresa, Ocaña, Marcos, Díaz-Gay, Sebastià, Franch-Expósito, Miriam, Cuatrecasas, Sabela, Carballal, Anael, Lopez-Novo, Lorena, Moreno, Guerau, Fernàndez, Aranzazu, Díaz de Bustamante, Sophia, Peters, Anna K, Sommer, Isabel, Spier, Iris B A W, Te Paske, Yasmijn J, van Herwaarden, Antoni, Castells, Luis, Bujanda, Gabriel, Capellà, Verena, Steinke-Lange, Khalid, Mahmood, JiHoon Eric, Joo, Julie, Arnold, Susan, Parry, Finlay A, Macrae, Ingrid M, Winship, Christophe, Rosty, Joaquin, Cubiella, Daniel, Rodríguez-Alcalde, Elke, Holinski-Feder, Richarda, de Voer, Daniel D, Buchanan, Stefan, Aretz, Clara, Ruiz-Ponte, Laura, Valle, Francesc, Balaguer, Laia, Bonjoch, and Sergi, Castellvi-Bel
- Abstract
Patients with serrated polyposis syndrome (SPS) have multiple and/or large serrated colonic polyps and higher risk for colorectal cancer. SPS inherited genetic basis is mostly unknown. We aimed to identify new germline predisposition factors for SPS by functionally evaluating a candidate gene and replicating it in additional SPS cohorts.After a previous whole-exome sequencing in 39 SPS patients from 16 families (discovery cohort), we sequenced specific genes in an independent validation cohort of 211 unrelated SPS cases. Additional external replication was also available in 297 SPS cases. TheWe identified 2 rare germline variants in theAfter whole-exome sequencing in SPS cases with familial aggregation and replication of results in additional cohorts, we identified rare germline variants in the
- Published
- 2022
40. Improving Antibiotic Use in Nursing Homes by Infection Prevention and Control and Antibiotic Stewardship (IMAGINE): Protocol for a Before-and-After Intervention and Implementation Study
- Author
-
Ana García-Sangenís, Daniela Modena, Jette Nygaard Jensen, Athina Chalkidou, Valeria S Antsupova, Tina Marloth, Anna Marie Theut, Beatriz González López-Valcárcel, Fabiana Raynal, Laura Vallejo-Torres, Jesper Lykkegaard, Malene Plejdrup Hansen, Jens Søndergaard, Jonas Kanstrup Olsen, Anders Munck, András Balint, Ria Benko, Davorina Petek, Nina Sodja, Anna Kowalczyk, Maciej Godycki-Cwirko, Helena Glasová, Jozef Glasa, Ruta Radzeviciene Jurgute, Lina Jaruseviciene, Christos Lionis, Marilena Anastasaki, Agapi Angelaki, Elena Petelos, Laura Alvarez, Marta Ricart, Sergi Briones, Georg Ruppe, Ramon Monfà, Anders Bjerrum, and Carl Llor
- Subjects
Medicine ,Computer applications to medicine. Medical informatics ,R858-859.7 - Abstract
BackgroundDespite the extensive use of antibiotics and the growing challenge of antimicrobial resistance, there has been a lack of substantial initiatives aimed at diminishing the prevalence of infections in nursing homes and enhancing the detection of urinary tract infections (UTIs). ObjectiveThis study aims to systematize and enhance efforts to prevent health care–associated infections, mainly UTIs and reduce antibiotic inappropriateness by implementing a multifaceted intervention targeting health care professionals in nursing homes. MethodsA before-and-after intervention study carried out in a minimum of 10 nursing homes in each of the 8 European participating countries (Denmark, Greece, Hungary, Lithuania, Poland, Slovakia, Slovenia, and Spain). A team of 4 professionals consisting of nurses, doctors, health care assistants, or health care helpers are actively involved in each nursing home. Over the initial 3-month period, professionals in each nursing home are registering information on UTIs as well as infection and prevention control measures by means of the Audit Project Odense method. The audit will be repeated after implementing a multifaceted intervention. The intervention will consist of feedback and discussion of the results from the first registration, training on the implementation of infection and prevention control techniques provided by experts, appropriateness of the diagnostic approach and antibiotic prescribing for UTIs, and provision of information materials on infection control and antimicrobial stewardship targeted to staff, residents, and relatives. We will compare the pre- and postintervention audit results using chi-square test for prescription appropriateness and Student t test for implemented hygiene elements. ResultsA total of 109 nursing homes have participated in the pilot study and the first registration audit. The results of the first audit registration are expected to be published in autumn of 2024. The final results will be published by the end of 2025. ConclusionsThis is a European Union–funded project aimed at contributing to the battle against antimicrobial resistance through improvement of the quality of management of common infections based on evidence-based interventions tailored to the nursing home setting and a diverse range of professionals. We expect the intervention to result in a significant increase in the number of hygiene activities implemented by health care providers and residents. Additionally, we anticipate a marked reduction in the number of inappropriately managed UTIs, as well as a substantial decrease in the overall incidence of infections following the intervention. International Registered Report Identifier (IRRID)DERR1-10.2196/60099
- Published
- 2024
- Full Text
- View/download PDF
41. TP53, a gene for colorectal cancer predisposition in the absence of Li-Fraumeni-associated phenotypes
- Author
-
Emma R. Woodward, Conxi Lázaro, D. Gareth Evans, Pau M. Munoz-Torres, George J Burghel, Gabriel Capellá, Mariona Terradas, Matilde Navarro, Marta Pineda, Isabel Quintana, Laura Valle, Victor Moreno, Pilar Mur, Sami Belhadj, and Joan Brunet
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,education.field_of_study ,medicine.diagnostic_test ,Molecular pathology ,business.industry ,Colorectal cancer ,Population ,Gastroenterology ,Cancer ,Gene mutation ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,Medical genetics ,Missense mutation ,business ,education ,Genetic testing - Abstract
ObjectiveGermline TP53 pathogenic (P) variants cause Li-Fraumeni syndrome (LFS), an aggressive multitumor-predisposing condition. Due to the implementation of multigene panel testing, TP53 variants have been detected in individuals without LFS suspicion, for example, patients with colorectal cancer (CRC). We aimed to decipher whether these findings are the result of detecting the background population prevalence or the aetiological basis of CRC.DesignWe analysed TP53 in 473 familial/early-onset CRC cases and evaluated the results together with five additional studies performed in patients with CRC (total n=6200). Control population and LFS data were obtained from Genome Aggregation Database (gnomAD V.2.1.1) and the International Agency for Research on Cancer (IARC) TP53 database, respectively. All variants were reclassified according to the guidelines of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP), following the ClinGen TP53 Expert Panel specifications.ResultsP or likely pathogenic (LP) variants were identified in 0.05% of controls (n=27/59 095) and 0.26% of patients with CRC (n=16/6200) (pTP53 testing. This association was still detected when patients with CRC diagnosed at more advanced ages (>50 and>60 years) were excluded from the analysis to minimise the inclusion of variants caused by clonal haematopoiesis. Loss-of-function and missense variants were strongly associated with CRC as compared with controls (OR=25.44, 95% CI 6.10 to 149.03, for loss of function and splice-site alleles, and OR=3.58, 95% CI 1.46 to 7.98, for missense P or LP variants).ConclusionTP53 P variants should not be unequivocally associated with LFS. Prospective follow-up of carriers of germline TP53 P variants in the absence of LFS phenotypes will define how surveillance and clinical management of these individuals should be performed.
- Published
- 2020
42. Expanding the phenotype of cerebellar‐facial‐dental syndrome: Two siblings with a novel variant in <scp> BRF1 </scp>
- Author
-
Irene Valenzuela, Paula Fernández-Álvarez, Laura Valle, Ivon Cuscó, Marta Codina, Pilar Mur, and Eduardo F Tizzano
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Microcephaly ,business.industry ,030105 genetics & heredity ,medicine.disease ,Bilateral sensorineural hearing impairment ,Short stature ,03 medical and health sciences ,030104 developmental biology ,Intellectual disability ,Genetics ,medicine ,Missense mutation ,Global developmental delay ,medicine.symptom ,business ,Cerebellar hypoplasia ,Genetics (clinical) ,Exome sequencing - Abstract
Cerebellofaciodental syndrome (MIM #616202) is an autosomal recessive condition characterized by intellectual disability, microcephaly, cerebellar hypoplasia, dysmorphic features, and short stature. To date, eight patients carrying biallelic BRF1 variants have been reported. Here, we describe two siblings with congenital microcephaly and corpus callosum hypoplasia, pre and postnatal growth retardation, congenital heart defect and severe global developmental delay. We also detected additional findings not previously reported in this syndrome, including bilateral sensorineural hearing impairment and inner ear malformation. Whole exome sequencing identified a novel homozygous missense variant (c.654G>C, p.[Trp218Cys]) in BRF1, predicted to affect the protein structure. Expression assessment showed extremely low BRF1 protein expression caused by the identified variant, supporting its causal involvement. The description of new patients with cerebellofaciodental syndrome is essential to better delineate the phenotypic and genotypic spectrum of the disease.
- Published
- 2020
43. Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review
- Author
-
Gabriel Capellá, Laura Valle, Matilde Navarro, Mariona Terradas, Gemma Aiza, Sami Belhadj, and Pau M. Munoz-Torres
- Subjects
Adult ,Candidate gene ,Adolescent ,Colorectal cancer ,DNA Mutational Analysis ,Biology ,Cohort Studies ,Young Adult ,03 medical and health sciences ,Germline mutation ,Genetics ,medicine ,Humans ,Genetic Predisposition to Disease ,Epigenetics ,Promoter Regions, Genetic ,Allele frequency ,Interleukin 12 receptor, beta 1 subunit ,Gene ,Early Detection of Cancer ,Genetics (clinical) ,Aged ,030304 developmental biology ,Aged, 80 and over ,0303 health sciences ,FAN1 ,Receptor-Like Protein Tyrosine Phosphatases, Class 3 ,030305 genetics & heredity ,DNA Methylation ,Middle Aged ,medicine.disease ,Colorectal Neoplasms - Abstract
Genome-wide approaches applied for the identification of new hereditary colorectal cancer (CRC) genes, identified several potential causal genes, including RPS20, IL12RB1, LIMK2, POLE2, MRE11, POT1, FAN1, WIF1, HNRNPA0, SEMA4A, FOCAD, PTPN12, LRP6, POLQ, BLM, MCM9, and the epigenetic inactivation of PTPRJ. Here we attempted to validate the association between variants in these genes and nonpolyposis CRC by performing a mutational screening of the genes and PTPRJ promoter methylation analysis in 473 familial/early-onset CRC cases, a systematic review of the published cases, and assessment of allele frequencies in control population. In the studied cohort, 24 (5%) carriers of (predicted) deleterious variants in the studied genes and no constitutional PTPRJ epimutations were identified. Assessment of allele frequencies in controls compared with familial/early-onset patients with CRC showed association with increased nonpolyposis CRC risk of disruptive variants in RPS20, IL12RB1, POLE2, MRE11 and POT1, and of FAN1 c.149T>G (p.Met50Arg). Lack of association was demonstrated for LIMK2, PTPN12, LRP6, PTPRJ, POLQ, BLM, MCM9 and FOCAD variants. Additional studies are required to provide conclusive evidence for SEMA4A, WIF1, HNRNPA0 c.-110G>C, and FOCAD large deletions.
- Published
- 2020
44. Potential Involvement of NSD1, KRT24 and ACACA in the Genetic Predisposition to Colorectal Cancer
- Author
-
Isabel Quintana, Pilar Mur, Mariona Terradas, Sandra García-Mulero, Gemma Aiza, Matilde Navarro, Virginia Piñol, Joan Brunet, Victor Moreno, Rebeca Sanz-Pamplona, Gabriel Capellá, and Laura Valle
- Subjects
Cancer Research ,Cribratge genètic ,cancer predisposition ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,polyposis ,somatic second hit ,Colorectal cancer ,Oncology ,hereditary cancer ,Càncer colorectal ,Genetic screening ,hereditary colorectal cancer ,Malalties hereditàries ,RC254-282 ,Genetic diseases - Abstract
The ALFRED (Allelic Loss Featuring Rare Damaging) in silico method was developed to identify cancer predisposition genes through the identification of somatic second hits. By applying ALFRED to ~10,000 tumor exomes, 49 candidate genes were identified. We aimed to assess the causal association of the identified genes with colorectal cancer (CRC) predisposition. Of the 49 genes, NSD1, HDAC10, KRT24, ACACA and TP63 were selected based on specific criteria relevant for hereditary CRC genes. Gene sequencing was performed in 736 patients with familial/early onset CRC or polyposis without germline pathogenic variants in known genes. Twelve (predicted) damaging variants in 18 patients were identified. A gene-based burden test in 1596 familial/early-onset CRC patients, 271 polyposis patients, 543 TCGA CRC patients and >134,000 controls (gnomAD, non-cancer), revealed no clear association with CRC for any of the studied genes. Nevertheless, (non-significant) over-representation of disruptive variants in NSD1, KRT24 and ACACA in CRC patients compared to controls was observed. A somatic second hit was identified in one of 20 tumors tested, corresponding to an NSD1 carrier. In conclusion, most genes identified through the ALFRED in silico method were not relevant for CRC predisposition, although a possible association was detected for NSD1, KRT24 and ACACA.
- Published
- 2022
45. Potential Involvement of
- Author
-
Isabel, Quintana, Pilar, Mur, Mariona, Terradas, Sandra, García-Mulero, Gemma, Aiza, Matilde, Navarro, Virginia, Piñol, Joan, Brunet, Victor, Moreno, Rebeca, Sanz-Pamplona, Gabriel, Capellá, and Laura, Valle
- Abstract
The ALFRED (Allelic Loss Featuring Rare Damaging) in silico method was developed to identify cancer predisposition genes through the identification of somatic second hits. By applying ALFRED to ~10,000 tumor exomes, 49 candidate genes were identified. We aimed to assess the causal association of the identified genes with colorectal cancer (CRC) predisposition. Of the 49 genes
- Published
- 2022
46. A QUESTÃO DA FORMA DE REMUNERAÇÃO NO TRABALHO EM PLATAFORMAS DIGITAIS
- Author
-
Laura Valle Gontijo
- Published
- 2022
47. Solving the genetic aetiology of hereditary gastrointestinal tumour syndromes- a collaborative multicentre endeavour within the project Solve-RD
- Author
-
Anna K. Sommer, Iris B.A.W. te Paske, José Garcia-Pelaez, Andreas Laner, Elke Holinski-Feder, Verena Steinke-Lange, Sophia Peters, Laura Valle, Isabel Spier, David Huntsman, Carla Oliveira, Richarda M. de Voer, Nicoline Hoogerbrugge, Stefan Aretz, Gabriel Capella, Gareth Evans, Andreas Rump, Evelin Schröck, Alexander Hoischen, Nicoline Geverink, Marc Tischkowitz, Leslie Matalonga, Steven Laurie, Christian Gilissen, Wouter Steyaert, and German Demidov
- Subjects
Genetic tumour risk syndromes ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,Omics ,Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6] ,Genomics ,General Medicine ,European reference network ,Tumour predisposition syndromes ,All institutes and research themes of the Radboud University Medical Center ,Neoplastic Syndromes, Hereditary ,ERN GENTURIS ,Exome Sequencing ,Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14] ,Genetics ,Humans ,Genetic Predisposition to Disease ,Colorectal Neoplasms ,Cancer genetics ,Genetics (clinical) - Abstract
Background: Patients and families with suspected, but genetically unexplained (unsolved) genetic tumour risk syndromes lack appropriate treatment and prevention, leading to preventable morbidity and mortality. To tackle this problem, patients from the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) are analysed in the European Commission's research project "Solving the unsolved rare diseases" (Solve-RD). The aim is to uncover known and novel cancer predisposing genes by reanalysing available whole-exome sequencing (WES) data of large cohorts in a combined manner, and applying a multidimensional omics approach. Approach: Around 500 genetically unsolved cases with suspected hereditary gastrointestinal tumour syndromes (polyposis, early-onset/familial colorectal cancer and gastric cancer) from multiple European centres are aimed to be included. Currently, clinical and germline WES data from 294 cases have been analysed. In addition, an extensive molecular profiling of gastrointestinal tumours from these patients is planned and deep learning techniques will be applied. The ambitious, multidisciplinary project is accompanied by a number of methodical, technical, and logistic challenges, which require the development and implementation of new analysis tools, the standardisation of bioinformatics pipelines, and strategies to exchange data and knowledge. Results: and Outlook. The first re-analysis of 229 known and proposed cancer predisposition genes allowed solving 2-3% of previously unsolved GENTURIS cases. The integration of expert knowledge and new technologies will help to identify the genetic basis of additional unsolved cases within the ongoing project. The ERN GENTURIS approach might serve as a model for other genomic initiatives. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 779257 (Solve-RD). This study makes use of data shared/provided through RD-Connect, which received funding from the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement No. 305444.
- Published
- 2022
48. Tumor mutation burden in colorectal cancers with POLE exonuclease and non-exonuclease domain variants
- Author
-
Salena Ringenbach, Shreya M. Shah, Elena Demidova, Bulat Faezov, Mark D. Andrake, Pilar Mur, Joanne Xiu, Wolfgang Michael Korn, Sanjay Goel, Heinz-Josef Lenz, John Marshall, Anthony Frank Shields, Matthew James Oberley, David Spetzler, Laura Valle, Roland Dunbrack, Michael J. Hall, and Sanjeevani Arora
- Subjects
Cancer Research ,Oncology - Abstract
224 Background: Driver mutations in the exonuclease domain (ExoD) of DNA polymerase epsilon ( POLE) have been associated with high tumor mutation burden (TMB). High TMB is an important marker for immunotherapy, and thus understanding the mechanisms that lead to high TMB is an area of active investigation. Many tumors with POLE ExoD driver mutations have additional POLE variants of uncertain significance (VUS). Some of these VUS lie within the ExoD, while most lie outside the ExoD. This study investigates the role of such POLE VUS on TMB and POLE functionality of ExoD-mutated tumors. Methods: Retrospective colorectal cancer (CRC) genomic profiles from Caris Life Sciences (n=1,870) were separated into groups based on the presence of POLE ExoD mutations and the TMB status. Groups were defined as: ‘TMB-high (TMB-H) POLE ExoD driver without additional POLE VUS’, ‘TMB-H POLE ExoD driver plus POLE VUS’, and ‘TMB-low (TMB-L) POLE variant(s) without ExoD driver’. An additional group with ‘TMB-H POLE variant(s) without ExoD driver’ was identified as potentially novel drivers for future study. The microsatellite instability status (MSI or MSS) was also considered. The level of TMB, the presence of polymerase proofreading-associated mutational signatures and POLE stability/functionality analyzed using AlphaFold2 models and Rosetta Molecular Modeling Suite, were evaluated. Results: POLE variants were identified in 4.9% of the CRCs studied (92/1870). In all, 52.2% (48/92) of those tumors were TMB-H, and 38.0% (35/92) of them contained POLE ExoD drivers. The highest median TMB (mTMB) was found in the ‘TMB-H POLE ExoD driver plus POLE VUS’ group, and this was significantly different from the ‘TMB-H POLE ExoD driver without additional POLE VUS’ and the ‘TMB-L POLE variant without ExoD driver’ group, even when MSI tumors were excluded (p
- Published
- 2023
49. Intermitência e trabalho em plataformas digitais : o retorno do salário por hora e por peça?
- Author
-
Gontijo, Laura Valle and Rosso, Sadi Dal
- Subjects
Reforma trabalhista ,Trabalho intermitente ,Salários ,Trabalho em plataformas digitais - Abstract
Dissertação (mestrado) — Universidade de Brasília, Instituto de Ciências Sociais, Departamento de Sociologia, 2021. Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Esta dissertação, com o título “Intermitência e trabalho em plataformas digitais: o retorno do salário por hora e por peça”, de autoria de Laura Valle Gontijo, sob orientação do professor doutor Sadi Dal Rosso, realizada no Departamento de Sociologia da Universidade de Brasília e defendida no dia 30 de novembro de 2021, tem como tema as formas mais recentes de trabalho precário, como o trabalho em plataformas digitais e o trabalho intermitente. Os objetivos desse trabalho são: contribuir com a investigação acerca do trabalho em plataforma digital e do trabalho intermitente, a partir do materialismo dialético, que permite compreender os fenômenos sociais na sua totalidade e no seu desenvolvimento histórico, e proporcionar elementos teóricos que contribuam para a formulação das reivindicações dos trabalhadores por melhores condições de vida e trabalho. É feito um resgate da discussão sobre salário por peça e por hora no volume I de “O Capital”, em Marx, e comparadas as suas características com o trabalho em plataformas digitais, a partir do resultado de um questionário aplicado com 87 entregadores, e com o trabalho intermitente, a partir de uma análise de dados da Relação Anual de Informações Sociais (Rais) e do Novo Cadastro Geral de Empregados e Desempregados (Novo Caged). Em um segundo momento, é feita uma discussão sobre as mudanças nas formas de remuneração ao longo do século XX e início do XXI, identificando elementos que corroboram com a hipótese da reintrodução do salário por peça e por hora, como forma de pagamento. Como conclusão, sugere-se que as reformas trabalhistas sinalizam um momento de transição de uma forma de remuneração para outra. Conclui-se que houve, de forma inequívoca, uma diminuição do nível de proteção ao emprego, na última década, e piora das condições de trabalho dos empregados formais. Observa-se um crescimento dos vínculos de trabalho precários, em detrimento dos vínculos estáveis. Há uma prevalência das longas jornadas, no caso dos trabalhadores em plataformas digitais, e de jornadas parciais, no caso dos trabalhadores intermitentes. Foi possível constatar ainda um alto nível de consciência política entre os trabalhadores em plataformas digitais, reconhecendo esse trabalho como uma escravidão ou semiescravidão e, prevalece uma divisão de opiniões entre os entregadores em relação à adoção da Carteira de Trabalho. This thesis “Intermittency and work on digital labour: a return of hourly and piece-based remuneration” by Laura Valle Gontijo, supervised by Professor Sadi Dal Rosso, PhD, defended at Departamento de Sociologia, Universidade de Brasília, on November, 30, 2021, appoaches the most recentlly forms of precarius labour, such as digital labour and intermittent labour. It ́s goals are to contribute for an investigation about digital labour and intermittent labour from the perspective of dialectical materialism, which allows a comprehensive understanding about social phenomena in a historical view and provide theoretical elements that contribute for proposing worker ́s demands for improving their living and working conditions. A reflexion about piece-based and hourly based remuneration was carried out on “The Capital – Vol 1”, by Karl Marx, comparing its characteristics with digital labour and intermittent labour, based on a survey regarding 87 deliverymen and with an intermittent labour according to government labour statistics (Relação Anual de Informações Sociais - Rais and Novo Cadastro Geral de Empregados e Desempregados - Novo Caged). In a second step the analysis follows a discussion regarding the changes in remuneration types that took place during the 20th and early ́s decades of 21st centuries, corroborating the hypothesis that piece and hourly remuneration are replacing standard 8-hours work day. It is argued that labour reforms have been introducing a new form of remuneration representing a transition phase. Evidence from official labour market statistics data, Rais and Novo Caged, point out a declining level of labour protection on the last decade, and a worsening working conditions of formal sector ́s employees. Data analysis revealed that precarious employment ́s relations have been increasing instead of formal jobs contracts. It also showed long working hours for digital workers and few working hours for intermittent ones. The survey with deliverymen on digital labour revealed that there is a high level of political awareness, with some of them referring to this work as slavery or semi-slavery and a dissent towards adopting or not formal working agreement.
- Published
- 2021
50. A Compreensão dos profissionais sobre a portaria GM/MS nº 1278/1999 que regulamenta o implante coclear : um estudo no Hospital Universitário de Brasília
- Author
-
Laura Valle Gontijo
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.